Conditional Risks of Biochemical Failure and Prostate Cancer–Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials

IMPORTANCE: As patients achieve years of survival after treatment for prostate cancer, the risk of biochemical failure (BF) or prostate cancer–specific death (PCSD) may evolve over time, with clinical relevance to both patients and clinicians. OBJECTIVE: To determine conditional BF–free survival, PS...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexander, Gregory S., Krc, Rebecca F., Assif, James W., Sun, Kai, Molitoris, Jason K., Tran, Phuoc, Rana, Zaker, Bentzen, Søren M., Mishra, Mark V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523164/
https://www.ncbi.nlm.nih.gov/pubmed/37751207
http://dx.doi.org/10.1001/jamanetworkopen.2023.35069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523164/
https://www.ncbi.nlm.nih.gov/pubmed/37751207
http://dx.doi.org/10.1001/jamanetworkopen.2023.35069

Ejemplares similares